Green Datacenter: Green named leading provider of data center services – for 5th consecutive year
Market research company ISG has once again named Green Switzerland’s leading data center provider. In the independent study, Green stood out for its superb range of services and strong customer focus.
Lupfig, July 17, 2024 – In the independent study “Private/Hybrid Cloud – Data Center Services 2024”, market research firm ISG analyzed the Swiss data center market. As part of a multi-stage survey, all service providers were evaluated in terms of their competitiveness and the attractiveness of their portfolio. Green emerged the clear leader, ahead of all other providers, taking top spot for data center services for a fifth consecutive year.
Excellent customer focus
In this year’s study, Green scored points for its strong customer focus, which gave it an extra edge over all other participating providers. Green’s speed and quality of implementation of customer projects, high degree of service innovation and first-rate operational excellence proved a winning combination. “The results of the study confirm that we excel in innovation and quality, and are highly rated thanks to our customer focus,” says Roger Süess, CEO of Green.
Future-oriented in an agile market
The authors of the study praised Green’s commitment to continuous development. “Green is planning for the future by creating additional capacities, has perfected its data center design to optimize energy efficiency, is extremely well positioned in the market, and is investing in new services, like connectivity, for example,” says Wolfgang Heinhaus, lead author of the study. The results show that Green consistently performs outstandingly well.
Green currently operates data centers in four locations and plans to continue to expand its capacities. Two new high-performance data centers are scheduled to go into operation in 2026.
About Green
Contact
+41 56 460 23 80
medien@green.ch
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
INTERSPORT Austria acquires INTERSPORT Slovenia Group15.1.2026 15:16:10 CET | Press release
Strategic move strengthens market position in Central Europe, with over 500 locations in 12 countries and more than € 1 billion in sales
VORN Bioenergy announces appointments to leadership team15.1.2026 11:14:45 CET | Press release
Regensburg. VORN Bioenergy today announces the appointment of Jörg Lennertz as Chief Executive Officer and Manuel Fernández Durán as Chief Financial Officer. Jörg and Manuel together with Michael Wallis Olausson form the new management team.
Vyoma’s first Space Domain Awareness satellite has reached orbit13.1.2026 13:42:00 CET | Press release
Munich, 13. January 2026 - Vyoma, a Germany-based company providing Space Domain Awareness (SDA) capabilities, has launched its pioneering surveillance satellite, Flamingo-1, on Sunday, January 11th, 2026 from Vandenberg Space Force Base, California, USA. It was launched aboard the Twilight rideshare mission with SpaceX via Germany-based launch integrator Exolaunch. The satellite was deployed to its operational Sun-synchronous orbit of approximately 500-km in altitude. This marks a significant achievement for the company, which patented the operational concept of an optimized SDA mission. Flamingo-1, equipped with an optical sensor for space-based space surveillance, is a gamechanger for Europe, strengthening SDA efforts directly from orbit. The advanced optical instrument will detect, track and characterize space objects, such as debris and other satellites. Crucially, it will allow Vyoma and its customers to follow up on manoeuvring objects and derive insights into adversary actions
ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner13.1.2026 09:00:00 CET | Press release
Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom